Abstract
Background: Acute bacterial cholangitis for the most part owing to common bile duct stones is common in gastroenterology practice and represents a potentially life-threatening condition often characterized by fever, abdominal pain, and jaundice (Charcot's triad) as well as confusion and septic shock (Reynolds' pentad). Methods: This review is based on a systematic literature review in PubMed with the search items ‘cholangitis', ‘choledocholithiasis', ‘gallstone disease', ‘biliary infection', and ‘biliary sepsis'. Results: Although most patients respond to empiric broad-spectrum antibiotic treatment, timely endoscopic biliary drainage depending on the severity of the disease is required to eliminate the underlying obstruction. Specific recommendations have been derived from the Tokyo guideline working group consensus 2006 and its update in 2013, albeit poorly evidence-based, providing a comprehensive overview of diagnosis, classification, risk stratification, and treatment algorithms in acute bacterial cholangitis. Conclusion: Prompt clinical recognition and accurate diagnostic workup including adequate laboratory assessment and (aetiology-oriented) imaging are critical steps in the management of cholangitis. Treatment is directed at the two major interrelated pathophysiologic components, i.e. bacterial infection (immediate antimicrobial therapy) and bile duct obstruction (biliary drainage). As for the latter, transpapillary endoscopic drainage by stent or nasobiliary drain and/or same-session bile duct clearance, depending on individual disease severity, represent first-line treatment approaches.
References
1.
Lammert F, Miquel JF: Gallstone disease: from genes to evidence-based therapy. J Hepatol 2008;48(suppl 1):S124-135.
2.
Neuhaus H, Feussner H, Ungeheuer A, Hoffmann W, Siewert JR, Classen M: Prospective evaluation of the use of endoscopic retrograde cholangiography prior to laparoscopic cholecystectomy. Endoscopy 1992;24:745-749.
3.
Friedman GD: Natural history of asymptomatic and symptomatic gallstones. Am J Surg 1993;165:399-404.
4.
Lee JG: Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol 2009;6:533-541.
5.
Parks RW, Clements WD, Smye MG, Pope C, Rowlands BJ, Diamond T: Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg 1996;83:1345-1349.
6.
Huang T, Bass JA, Williams RD: The significance of biliary pressure in cholangitis. Arch Surg 1969;98:629-632.
7.
Csendes A, Sepulveda A, Burdiles P, Braghetto I, Bastias J, Schutte H, Diaz JC, Yarmuch J, Maluenda F: Common bile duct pressure in patients with common bile duct stones with or without acute suppurative cholangitis. Arch Surg 1988;123:697-699.
8.
Swidsinski A, Lee SP: The role of bacteria in gallstone pathogenesis. Front Biosci 2001;6:E93-103.
9.
Kumar R, Sharma BC, Singh J, Sarin SK: Endoscopic biliary drainage for severe acute cholangitis in biliary obstruction as a result of malignant and benign diseases. J Gastroenterol Hepatol 2004;19:994-997.
10.
Landau O, Kott I, Deutsch AA, Stelman E, Reiss R: Multifactorial analysis of septic bile and septic complications in biliary surgery. World J Surg 1992;16:962-964; discussion 964-965.
11.
Reynolds BM, Dargan EL: Acute obstructive cholangitis; a distinct clinical syndrome. Ann Surg 1959;150:299-303.
12.
Csendes A, Diaz JC, Burdiles P, Maluenda F, Morales E: Risk factors and classification of acute suppurative cholangitis. Br J Surg 1992;79:655-658.
13.
Agarwal N, Sharma BC, Sarin SK: Endoscopic management of acute cholangitis in elderly patients. World J Gastroenterol 2006;12:6551-6555.
14.
Saharia PC, Cameron JL: Clinical management of acute cholangitis. Surg Gynecol Obstet 1976;142:369-372.
15.
Wada K, Takada T, Kawarada Y, et al: Diagnostic criteria and severity assessment of acute cholangitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg 2007;14:52-58.
16.
Einstein DM, Lapin SA, Ralls PW, Halls JM: The insensitivity of sonography in the detection of choledocholithiasis. AJR Am J Roentgenol 1984;142:725-728.
17.
Taylor KJ, Rosenfield AT, Spiro HM: Diagnostic accuracy of gray scale ultrasonography for the jaundiced patient. A report of 275 cases. Arch Intern Med 1979;139:60-63.
18.
Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J: Functional gallbladder and sphincter of oddi disorders. Gastroenterology 2006;130:1498-1509.
19.
Demartines N, Eisner L, Schnabel K, Fried R, Zuber M, Harder F: Evaluation of magnetic resonance cholangiography in the management of bile duct stones. Arch Surg 2000;135:148-152.
20.
Soto JA, Barish MA, Alvarez O, Medina S: Detection of choledocholithiasis with MR cholangiography: comparison of three-dimensional fast spin-echo and single- and multisection half-fourier rapid acquisition with relaxation enhancement sequences. Radiology 2000;215:737-745.
21.
Amouyal P, Amouyal G, Levy P, Tuzet S, Palazzo L, Vilgrain V, Gayet B, Belghiti J, Fekete F, Bernades P: Diagnosis of choledocholithiasis by endoscopic ultrasonography. Gastroenterology 1994;106:1062-1067.
22.
Sgouros SN, Bergele C: Endoscopic ultrasonography versus other diagnostic modalities in the diagnosis of choledocholithiasis. Dig Dis Sci 2006;51:2280-2286.
23.
Rocca R, De Angelis C, Castellino F, Masoero G, Daperno M, Sostegni R, Rigazio C, Crocella L, Lavagna A, Ercole E, Pera A: EUS diagnosis and simultaneous endoscopic retrograde cholangiography treatment of common bile duct stones by using an oblique-viewing echoendoscope. Gastrointest Endosc 2006;63:479-484.
24.
Ozden I, Tekant Y, Bilge O, Acarli K, Alper A, Emre A, Rozanes I, Ozsut H, Ariogul O: Endoscopic and radiologic interventions as the leading causes of severe cholangitis in a tertiary referral center. Am J Surg 2005;189:702-706.
25.
Verma D, Kapadia A, Eisen GM, Adler DG: EUS vs MRCP for detection of choledocholithiasis. Gastrointest Endosc 2006;64:248-254.
26.
Attasaranya S, Fogel EL, Lehman GA: Choledocholithiasis, ascending cholangitis, and gallstone pancreatitis. Med Clin North Am 2008;92:925-960, x.
27.
Nishino T, Hamano T, Mitsunaga Y, Shirato I, Shirato M, Tagata T, Shimada M, Yoshida S, Mitsunaga A: Clinical evaluation of the Tokyo guidelines 2013 for severity assessment of acute cholangitis. J Hepatobiliary Pancreat Sci 2014;21:841-849.
28.
Sung JY, Shaffer EA, Olson ME, Leung JW, Lam K, Costerton JW: Bacterial invasion of the biliary system by way of the portal-venous system. Hepatology 1991;14:313-317.
29.
Sung JY, Leung JW, Shaffer EA, Lam K, Olson ME, Costerton JW: Ascending infection of the biliary tract after surgical sphincterotomy and biliary stenting. J Gastroenterol Hepatol 1992;7:240-245.
30.
Dellinger RP, Levy MM, Rhodes A, et al: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228.
31.
Tanaka A, Takada T, Kawarada Y, et al: Antimicrobial therapy for acute cholangitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg 2007;14:59-67.
32.
Stallmach A, Hagel S, Bruns T, Pletz M, Eckmann C: Empirical antibiotic therapy in intra-abdominal infections: cases and evidence-based therapeutic recommendations (Article in German). Z Gastroenterol 2013;51:1069-1081.
33.
van Lent AU, Bartelsman JF, Tytgat GN, Speelman P, Prins JM: Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract. Gastrointest Endosc 2002;55:518-522.
34.
Sung YK, Lee JK, Lee KH, Lee KT, Kang CI: The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens. Am J Gastroenterol 2012;107:473-483.
35.
Kirchner GI, Ruemmele P: Update on sclerosing cholangitis in critically ill patients. Viszeralmedizin 2015;31:178-184.
36.
Kirchner GI, Scherer MN, Obed A, Ruemmele P, Wiest R, Froh M, Loss M, Schlitt HJ, Scholmerich J, Gelbmann CM: Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation. Scand J Gastroenterol 2011;46:471-478.
37.
Voigtlander T, Negm AA, Schneider AS, Strassburg CP, Manns MP, Wedemeyer J, Lankisch TO: Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome. Endoscopy 2012;44:1055-1058.
38.
Gomi H, Solomkin JS, Takada T, Strasberg SM, Pitt HA, Yoshida M, Kusachi S, Mayumi T, Miura F, Kiriyama S, Yokoe M, Kimura Y, Higuchi R, Windsor JA, Dervenis C, Liau KH, Kim MH: TG13 antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2013;20:60-70.
39.
van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ: Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis 1994;19:279-286.
40.
Leung JW, Chan RC, Cheung SW, Sung JY, Chung SC, French GL: The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime. J Antimicrob Chemother 1990;25:399-406.
41.
Kimura Y, Takada T, Strasberg SM, et al: TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2013;20:8-23.
42.
Mosler P: Diagnosis and management of acute cholangitis. Curr Gastroenterol Rep 2011;13:166-172.
43.
Lee DW, Chan AC, Lam YH, Ng EK, Lau JY, Law BK, Lai CW, Sung JJ, Chung SC: Biliary decompression by nasobiliary catheter or biliary stent in acute suppurative cholangitis: a prospective randomized trial. Gastrointest Endosc 2002;56:361-365.
44.
De Palma GD, Galloro G, Siciliano S, Iovino P, Catanzano C: Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 2001;53:547-553.
45.
NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens State Sci Statements 2002;19:1-26.
46.
ASGE Standards of Practice Committee; Chathadi KV, Chandrasekhara V, Acosta RD, et al: The role of ERCP in benign diseases of the biliary tract. Gastrointest Endosc 2015;81:795-803.
47.
Hintze RE, Abou-Rebyeh H, Adler A, Veltzke-Schlieker W, Felix R, Wiedenmann B: Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc 2001;53:40-46.
48.
Carr-Locke DL: Therapeutic role of ERCP in the management of suspected common bile duct stones. Gastrointest Endosc 2002;56:S170-174.
49.
Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JD, Pheley AM: Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-918.
50.
Sarkaria S, Sundararajan S, Kahaleh M: Endoscopic ultrasonographic access and drainage of the common bile duct. Gastrointest Endosc Clin N Am 2013;23:435-452.
51.
Park do H, Jeong SU, Lee BU, Lee SS, Seo DW, Lee SK, Kim MH: Prospective evaluation of a treatment algorithm with enhanced guidewire manipulation protocol for EUS-guided biliary drainage after failed ERCP (with video). Gastrointest Endosc 2013;78:91-101.
52.
Leung JW, Tu R: Mechanical lithotripsy for large bile duct stones. Gastrointest Endosc 2004;59:688-690.
53.
Attila T, May GR, Kortan P: Nonsurgical management of an impacted mechanical lithotriptor with fractured traction wires: endoscopic intracorporeal electrohydraulic shock wave lithotripsy followed by extra-endoscopic mechanical lithotripsy. Can J Gastroenterol 2008;22:699-702.
54.
Trikudanathan G, Arain MA, Attam R, Freeman ML: Advances in the endoscopic management of common bile duct stones. Nat Rev Gastroenterol Hepatol 2014;11:535-544.
55.
Maydeo A, Kwek BE, Bhandari S, Bapat M, Dhir V: Single-operator cholangioscopy-guided laser lithotripsy in patients with difficult biliary and pancreatic ductal stones (with videos). Gastrointest Endosc 2011;74:1308-1314.
56.
Piraka C, Shah RJ, Awadallah NS, Langer DA, Chen YK: Transpapillary cholangioscopy-directed lithotripsy in patients with difficult bile duct stones. Clin Gastroenterol Hepatol 2007;5:1333-1338.
57.
Arya N, Nelles SE, Haber GB, Kim YI, Kortan PK: Electrohydraulic lithotripsy in 111 patients: a safe and effective therapy for difficult bile duct stones. Am J Gastroenterol 2004;99:2330-2334.
58.
Farrell JJ, Bounds BC, Al-Shalabi S, Jacobson BC, Brugge WR, Schapiro RH, Kelsey PB: Single-operator duodenoscope-assisted cholangioscopy is an effective alternative in the management of choledocholithiasis not removed by conventional methods, including mechanical lithotripsy. Endoscopy 2005;37:542-547.
59.
Binmoeller KF, Bruckner M, Thonke F, Soehendra N: Treatment of difficult bile duct stones using mechanical, electrohydraulic and extracorporeal shock wave lithotripsy. Endoscopy 1993;25:201-206.
60.
Boerma D, Rauws EA, Keulemans YC, Janssen IM, Bolwerk CJ, Timmer R, Boerma EJ, Obertop H, Huibregtse K, Gouma DJ: Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile-duct stones: a randomised trial. Lancet 2002;360:761-765.
61.
Pereira-Lima JC, Jakobs R, Winter UH, Benz C, Martin WR, Adamek HE, Riemann JF: Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms. Gastrointest Endosc 1998;48:457-464.
62.
Yi SY: Recurrence of biliary symptoms after endoscopic sphincterotomy for choledocholithiasis in patients with gall bladder stones. J Gastroenterol Hepatol 2000;15:661-664.
63.
Lau JY, Leow CK, Fung TM, Suen BY, Yu LM, Lai PB, Lam YH, Ng EK, Lau WY, Chung SS, Sung JJ: Cholecystectomy or gallbladder in situ after endoscopic sphincterotomy and bile duct stone removal in Chinese patients. Gastroenterology 2006;130:96-103.
64.
Kiriyama S, Takada T, Strasberg SM, et al: TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci 2013;20:24-34.
65.
Miura F, Takada T, Strasberg SM, et al: TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2013;20:47-54.
© 2015 S. Karger GmbH, Freiburg
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
